 | • レポートコード：MRC308GR11471 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のmRNAワクチンコア酵素の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のmRNAワクチンコア酵素市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– mRNAワクチンコア酵素の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
mRNAワクチンコア酵素市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・mRNAキャッピング酵素、mRNA T7ポリメラーゼ、無機ピロホスファターゼ、2’O-メチルトランスフェラーゼ、その他
用途別セグメント
・ワクチン研究開発、基礎研究、その他
主要な市場プレーヤー
・Thermo Fisher Scientific、Novoprotein Scientific、NEB、Shanghai Hongene Biotech、Yeasen Biotechnology、Aldevron、Takara Bio Inc.、Vazyme Biotech、Promega、TriLink Bio Technologies
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、mRNAワクチンコア酵素製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なmRNAワクチンコア酵素メーカーの企業概要、2019年～2022年までのmRNAワクチンコア酵素の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なmRNAワクチンコア酵素メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別mRNAワクチンコア酵素の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのmRNAワクチンコア酵素の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのmRNAワクチンコア酵素市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびmRNAワクチンコア酵素の産業チェーンを掲載しています。
・第14、15章では、mRNAワクチンコア酵素の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– mRNAワクチンコア酵素の概要
– 種類別分析（2018年vs2022年vs2029年）：mRNAキャッピング酵素、mRNA T7ポリメラーゼ、無機ピロホスファターゼ、2’O-メチルトランスフェラーゼ、その他
– 用途別分析（2018年vs2022年vs2029年）：ワクチン研究開発、基礎研究、その他
– 世界のmRNAワクチンコア酵素市場規模・予測
– 世界のmRNAワクチンコア酵素生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Thermo Fisher Scientific、Novoprotein Scientific、NEB、Shanghai Hongene Biotech、Yeasen Biotechnology、Aldevron、Takara Bio Inc.、Vazyme Biotech、Promega、TriLink Bio Technologies
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：mRNAキャッピング酵素、mRNA T7ポリメラーゼ、無機ピロホスファターゼ、2’O-メチルトランスフェラーゼ、その他
・用途別分析2018年-2029年：ワクチン研究開発、基礎研究、その他
・mRNAワクチンコア酵素の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・mRNAワクチンコア酵素のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・mRNAワクチンコア酵素のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・mRNAワクチンコア酵素の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・mRNAワクチンコア酵素の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of mRNA Vaccine Core Enzyme
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccine Core Enzyme Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 mRNA Capping Enzyme
1.3.3 mRNA T7 Polymerase
1.3.4 Inorganic Pyrophosphatase
1.3.5 2′O-Methyltransferase
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Vaccine Core Enzyme Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Vaccine Research And Development
1.4.3 Basic Research
1.4.4 Others
1.5 Global mRNA Vaccine Core Enzyme Market Size & Forecast
1.5.1 Global mRNA Vaccine Core Enzyme Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Vaccine Core Enzyme Sales Quantity (2018-2029)
1.5.3 Global mRNA Vaccine Core Enzyme Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific mRNA Vaccine Core Enzyme Product and Services
2.1.4 Thermo Fisher Scientific mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Novoprotein Scientific
2.2.1 Novoprotein Scientific Details
2.2.2 Novoprotein Scientific Major Business
2.2.3 Novoprotein Scientific mRNA Vaccine Core Enzyme Product and Services
2.2.4 Novoprotein Scientific mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novoprotein Scientific Recent Developments/Updates
2.3 NEB
2.3.1 NEB Details
2.3.2 NEB Major Business
2.3.3 NEB mRNA Vaccine Core Enzyme Product and Services
2.3.4 NEB mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 NEB Recent Developments/Updates
2.4 Shanghai Hongene Biotech
2.4.1 Shanghai Hongene Biotech Details
2.4.2 Shanghai Hongene Biotech Major Business
2.4.3 Shanghai Hongene Biotech mRNA Vaccine Core Enzyme Product and Services
2.4.4 Shanghai Hongene Biotech mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Hongene Biotech Recent Developments/Updates
2.5 Yeasen Biotechnology
2.5.1 Yeasen Biotechnology Details
2.5.2 Yeasen Biotechnology Major Business
2.5.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
2.5.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Yeasen Biotechnology Recent Developments/Updates
2.6 Aldevron
2.6.1 Aldevron Details
2.6.2 Aldevron Major Business
2.6.3 Aldevron mRNA Vaccine Core Enzyme Product and Services
2.6.4 Aldevron mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aldevron Recent Developments/Updates
2.7 Takara Bio Inc.
2.7.1 Takara Bio Inc. Details
2.7.2 Takara Bio Inc. Major Business
2.7.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
2.7.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takara Bio Inc. Recent Developments/Updates
2.8 Vazyme Biotech
2.8.1 Vazyme Biotech Details
2.8.2 Vazyme Biotech Major Business
2.8.3 Vazyme Biotech mRNA Vaccine Core Enzyme Product and Services
2.8.4 Vazyme Biotech mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Vazyme Biotech Recent Developments/Updates
2.9 Promega
2.9.1 Promega Details
2.9.2 Promega Major Business
2.9.3 Promega mRNA Vaccine Core Enzyme Product and Services
2.9.4 Promega mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Promega Recent Developments/Updates
2.10 TriLink Bio Technologies
2.10.1 TriLink Bio Technologies Details
2.10.2 TriLink Bio Technologies Major Business
2.10.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
2.10.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 TriLink Bio Technologies Recent Developments/Updates
3 Competitive Environment: mRNA Vaccine Core Enzyme by Manufacturer
3.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Vaccine Core Enzyme Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Vaccine Core Enzyme Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Vaccine Core Enzyme Manufacturer Market Share in 2022
3.5 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccine Core Enzyme Market: Region Footprint
3.5.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
3.5.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global mRNA Vaccine Core Enzyme Market Size by Region
4.1.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Vaccine Core Enzyme Average Price by Region (2018-2029)
4.2 North America mRNA Vaccine Core Enzyme Consumption Value (2018-2029)
4.3 Europe mRNA Vaccine Core Enzyme Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value (2018-2029)
4.5 South America mRNA Vaccine Core Enzyme Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Vaccine Core Enzyme Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
5.2 Global mRNA Vaccine Core Enzyme Consumption Value by Type (2018-2029)
5.3 Global mRNA Vaccine Core Enzyme Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
6.2 Global mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
6.3 Global mRNA Vaccine Core Enzyme Average Price by Application (2018-2029)
7 North America
7.1 North America mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
7.2 North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
7.3 North America mRNA Vaccine Core Enzyme Market Size by Country
7.3.1 North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Vaccine Core Enzyme Market Size by Country
8.3.1 Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Vaccine Core Enzyme Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
10.2 South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
10.3 South America mRNA Vaccine Core Enzyme Market Size by Country
10.3.1 South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Vaccine Core Enzyme Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 mRNA Vaccine Core Enzyme Market Drivers
12.2 mRNA Vaccine Core Enzyme Market Restraints
12.3 mRNA Vaccine Core Enzyme Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of mRNA Vaccine Core Enzyme and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccine Core Enzyme
13.3 mRNA Vaccine Core Enzyme Production Process
13.4 mRNA Vaccine Core Enzyme Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccine Core Enzyme Typical Distributors
14.3 mRNA Vaccine Core Enzyme Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global mRNA Vaccine Core Enzyme Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Vaccine Core Enzyme Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific mRNA Vaccine Core Enzyme Product and Services
Table 6. Thermo Fisher Scientific mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Thermo Fisher Scientific Recent Developments/Updates
Table 8. Novoprotein Scientific Basic Information, Manufacturing Base and Competitors
Table 9. Novoprotein Scientific Major Business
Table 10. Novoprotein Scientific mRNA Vaccine Core Enzyme Product and Services
Table 11. Novoprotein Scientific mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novoprotein Scientific Recent Developments/Updates
Table 13. NEB Basic Information, Manufacturing Base and Competitors
Table 14. NEB Major Business
Table 15. NEB mRNA Vaccine Core Enzyme Product and Services
Table 16. NEB mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. NEB Recent Developments/Updates
Table 18. Shanghai Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 19. Shanghai Hongene Biotech Major Business
Table 20. Shanghai Hongene Biotech mRNA Vaccine Core Enzyme Product and Services
Table 21. Shanghai Hongene Biotech mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shanghai Hongene Biotech Recent Developments/Updates
Table 23. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Yeasen Biotechnology Major Business
Table 25. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
Table 26. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Yeasen Biotechnology Recent Developments/Updates
Table 28. Aldevron Basic Information, Manufacturing Base and Competitors
Table 29. Aldevron Major Business
Table 30. Aldevron mRNA Vaccine Core Enzyme Product and Services
Table 31. Aldevron mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aldevron Recent Developments/Updates
Table 33. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Takara Bio Inc. Major Business
Table 35. Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
Table 36. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takara Bio Inc. Recent Developments/Updates
Table 38. Vazyme Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Vazyme Biotech Major Business
Table 40. Vazyme Biotech mRNA Vaccine Core Enzyme Product and Services
Table 41. Vazyme Biotech mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Vazyme Biotech Recent Developments/Updates
Table 43. Promega Basic Information, Manufacturing Base and Competitors
Table 44. Promega Major Business
Table 45. Promega mRNA Vaccine Core Enzyme Product and Services
Table 46. Promega mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Promega Recent Developments/Updates
Table 48. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 49. TriLink Bio Technologies Major Business
Table 50. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
Table 51. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. TriLink Bio Technologies Recent Developments/Updates
Table 53. Global mRNA Vaccine Core Enzyme Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global mRNA Vaccine Core Enzyme Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global mRNA Vaccine Core Enzyme Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in mRNA Vaccine Core Enzyme, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and mRNA Vaccine Core Enzyme Production Site of Key Manufacturer
Table 58. mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
Table 59. mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
Table 60. mRNA Vaccine Core Enzyme New Market Entrants and Barriers to Market Entry
Table 61. mRNA Vaccine Core Enzyme Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global mRNA Vaccine Core Enzyme Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global mRNA Vaccine Core Enzyme Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global mRNA Vaccine Core Enzyme Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global mRNA Vaccine Core Enzyme Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global mRNA Vaccine Core Enzyme Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global mRNA Vaccine Core Enzyme Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global mRNA Vaccine Core Enzyme Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global mRNA Vaccine Core Enzyme Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global mRNA Vaccine Core Enzyme Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Region (2024-2029) & (USD Million)
Table 120. mRNA Vaccine Core Enzyme Raw Material
Table 121. Key Manufacturers of mRNA Vaccine Core Enzyme Raw Materials
Table 122. mRNA Vaccine Core Enzyme Typical Distributors
Table 123. mRNA Vaccine Core Enzyme Typical Customers
List of Figures
Figure 1. mRNA Vaccine Core Enzyme Picture
Figure 2. Global mRNA Vaccine Core Enzyme Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Type in 2022
Figure 4. mRNA Capping Enzyme Examples
Figure 5. mRNA T7 Polymerase Examples
Figure 6. Inorganic Pyrophosphatase Examples
Figure 7. 2′O-Methyltransferase Examples
Figure 8. Others Examples
Figure 9. Global mRNA Vaccine Core Enzyme Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Application in 2022
Figure 11. Vaccine Research And Development Examples
Figure 12. Basic Research Examples
Figure 13. Others Examples
Figure 14. Global mRNA Vaccine Core Enzyme Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global mRNA Vaccine Core Enzyme Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global mRNA Vaccine Core Enzyme Sales Quantity (2018-2029) & (K Units)
Figure 17. Global mRNA Vaccine Core Enzyme Average Price (2018-2029) & (US$/Unit)
Figure 18. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 mRNA Vaccine Core Enzyme Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 mRNA Vaccine Core Enzyme Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2018-2029)
Figure 25. North America mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 28. South America mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value (2018-2029) & (USD Million)
Figure 30. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Type (2018-2029)
Figure 32. Global mRNA Vaccine Core Enzyme Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2029)
Figure 35. Global mRNA Vaccine Core Enzyme Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 40. United States mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2018-2029)
Figure 56. China mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa mRNA Vaccine Core Enzyme Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. mRNA Vaccine Core Enzyme Market Drivers
Figure 77. mRNA Vaccine Core Enzyme Market Restraints
Figure 78. mRNA Vaccine Core Enzyme Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of mRNA Vaccine Core Enzyme in 2022
Figure 81. Manufacturing Process Analysis of mRNA Vaccine Core Enzyme
Figure 82. mRNA Vaccine Core Enzyme Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source